Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients

被引:61
作者
A. W. Eckert
M. Kappler
J. Schubert
H. Taubert
机构
[1] Department of Oral and Maxillofacial Plastic Surgery, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Saale
[2] Division of Molecular Urology, Clinic of Urology FA University Hospital Erlangen, 91054 Erlangen
关键词
HIF; Hypoxia; Oral squamous cell carcinoma; Pathways;
D O I
10.1007/s10006-012-0335-8
中图分类号
学科分类号
摘要
Introduction: Hypoxia plays a major role in tumor progression, therapy resistance and for prognosis of oral squamous cell carcinoma (OSCC). The crucial step as a response to hypoxia is the activation and stabilization of the alpha subunit of hypoxia inducible factor 1 (HIF-1α). HIF-1: HIF-1 regulates the expression of different genes to adapt the tumor cells to reduced oxygenation. The HIF-1 system is intrinsic regulated by von Hippel-Lindau protein (pVHL). Main downstream proteins are the glucose transporter 1 (GLUT-1), carbonic anhydrase IX (CAIX), and vascular endothelial growth factor (VEGF). For therapeutical stratification in OSCC, it is important to understand the mechanism caused by hypoxic stress and to comprehend the resulting adaptive process in cancer cells. Therefore, an overview of HIF-1α-depending protein expression, focussed on the expression of GLUT-1, CAIX, and VEGF and their prognostic significance in OSCC is given. Conclusion: Several unique roles of hypoxic pathway in the context of tumor progression are described in this review. As a consequence, a marker panel is proposed to allow a more individualized prognosis in OSCC patients. This marker panel should include beside HIF-1α, pVHL, and GLUT-1. © 2012 Springer-Verlag.
引用
收藏
页码:189 / 196
页数:7
相关论文
共 84 条
[1]  
Abreu L., Kruger E., Tennant M., Oral cancer in Western Australia: 1982-2006: a retrospective epidemiological study, Oral Pathol Med, 39, pp. 376-381, (2010)
[2]  
Zini A., Czerninski R., Sgan-Cohen H.D., Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites, Oral Pathol Med, 39, pp. 299-305, (2010)
[3]  
Oliveira L.R., Ribeiro-Silva A., Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma, Int J Oral Maxillofac Surg, 40, pp. 298-307, (2011)
[4]  
Schliephake H., Prognostic relevance of molecular markers of oral cancer-a review, Int J Oral Maxillofac Surg, 32, pp. 233-245, (2003)
[5]  
Lothaire P., Azambuja E., Dequanter D., Lalami Y., Sotiriou C., Andry G., Castro G., Awada A., Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation, Head Neck, 28, pp. 256-269, (2006)
[6]  
Kim K.Y., Li S., Cha J.D., Zhang X., Cha I.H., Significance of molecular markers in survival prediction of oral squamous call carcinoma, Head Neck, (2011)
[7]  
Perez-Sayans M., Suarez-Penaranda J.M., Pilar G.D., Barros-Angueira F., Gandara-Rey J.M., Garcia-Garcia A., Hypoxia-inducible factors in OSCC, Cancer Lett, 313, pp. 1-8, (2011)
[8]  
Cassavaugh J., Luonsbury K.M., Hypoxia-mediated biological control, J Cell Biochem, 112, pp. 735-744, (2011)
[9]  
Semenza G.L., Hypoxia-inducible factor 1 and cancer pathogenesis, IUBMB Life, 60, pp. 591-597, (2008)
[10]  
Semenza G.L., HIF-1: upstream and downstream of cancer metabolism, Curr Opin Genet Dev, 20, pp. 1-6, (2009)